Skip to main content
Premium Trial:

Request an Annual Quote

Call to Fill FDA Spot

Half a dozen former commissioners of the US Food and Drug Administration are calling on President Joe Biden to nominate a new agency head, Stat News reports.

Stephen Hahn stepped down from the post with the change in administrations and, currently, Janet Woodcock is serving as the acting FDA commissioner. Mark McClellan, FDA commissioner during the Bush Administration and a signatory of the new letter, told Politico in January filling the spot should be a priority during a pandemic.

In a letter to President Biden, the former commissioners — who also include Robert Califf, Scott Gottlieb, Margaret Hamburg, Jane Henney, and Andrew von Eschenbach — echo that sentiment, saying that the agency "is playing a critical role in our nation's response to the COVID pandemic."

"To continue to advance the agency's mission, and promote its independent role, we urge you to prioritize securing its leadership team, including through seeking the formal nomination and confirmation of an FDA Commissioner," they add.

The New York Times reported last month that Woodcock and Joshua Sharfstein, who was deputy commissioner at FDA during the Obama Administration, are leading candidates for the post, but that others including David Kessler, Amy Abernethy, FDA's principal deputy commissioner; and Luciana Borio, a former acting chief scientist at FDA have also been considered.

The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Targets Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.